EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Intranuclear localisation of KLF3‐AS1 under the balance of histone acetylation and methylation in BMSCs ameliorates cerebral ischaemia‒reperfusion injury by preserving microglial mitochondrial function and inhibiting inflammatory polarisation

Qian Li, Xiaowei Xie, Jie Chen, Yu Cao, Dingzhou Zhou iD

Clinical and Translational Medicine · 2026-11 · 16 (11)

DOI: 10.1002/ctm2.70870 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical and Translational Medicine, online erschienen am 31.10.2026. Verfasst von Qian Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traditional Chinese Medicine, Hunan Provincial People's Hospital (The First Affiliated Hospital of Hunan Normal University), Changsha, …. Hauptthemen laut MEDLINE: Reperfusion Injury, Microglia, Mesenchymal Stem Cells, Histones. Die Arbeit nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hunan Furong Program Young Talent Project, Health Research Project of Hunan Provincial Health Commission, Hunan Province Cerebrovascular Disease Rehabilitation Clinical Medical Technology Demonstration Base.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ischaemic stroke occurs when blood flow to the brain is obstructed. Rapid restoration of blood supply frequently induces cerebral ischaemia‒reperfusion injury (CIRI). Bone marrow mesenchymal stem cell (BMSC)‐derived exosomes exhibit promising therapeutic potential for CIRI. In‐depth exploration of their therapeutic mechanisms holds crucial significance for CIRI management.

Methods

The middle cerebral artery occlusion/reperfusion (MCAO) model was established in mice. An in vitro ischaemic stroke model was established by treating BV‐2 cells with oxygen‒glucose deprivation/reoxygenation (OGD/R). Exosomes were isolated from BMSCs and intranasally administrated into mice or added into BV‐2 cells. Neurological deficits, grasping and coordination function were evaluated. Cell viability, apoptosis, proliferation and migration were examined. The localisation of KLF3‐AS1 was examined by combined staining of immunofluorescence and fluorescence in situ hybridisation. Intracellular Ca 2+ and adenosine triphosphate levels, mitochondrial reactive oxygen species and membrane potential were assessed.

Results

KLF3‐AS1 enhanced BMSC viability, proliferation and migration, accompanied by epigenetic reprogramming at its promoter characterised by increased H3K27 acetylation (H3K27Ac) and decreased H3K27 trimethylation (H3K27Me3). BMSC‐derived KLF3‐AS1‐enriched exosomes indicated therapeutic efficacy in both in vivo and in vitro models of cerebral ischaemia. In MCAO‐induced mice, these exosomes alleviated neurological deficits and shifted microglial polarisation from pro‐inflammatory M1‐like to anti‐inflammatory M2‐like phenotypes. Similar effects were observed in OGD/R‐treated BV‐2 microglia, where KLF3‐AS1‐enriched exosomes attenuated oxidative stress and mitochondrial dysfunction while upregulating Silent Information Regulator 3 (SIRT3) expression. Mechanistically, KLF3‐AS1 facilitated ETS Variant Transcription Factor 4 (ETV4) nuclear translocation to activate SIRT3 transcription in microglia, and inhibition of SIRT3 abolished the neuroprotective effects of exosomal KLF3‐AS1.

Conclusion

BMSC‐derived exosomes delivering KLF3‐AS1 ameliorates CIRI by preserving microglial mitochondrial function and inhibiting inflammatory polarisation, highlighting KLF3‐AS1 as a critical epigenetic regulator and exosome‐mediated therapeutic agent for CIRI through the ETV4/SIRT3 axis. Key points/Highlights KLF3‐AS1 enhances bone marrow mesenchymal stem cell (BMSC) function via promoter H3K27Ac/H3K27Me3 reprogramming. KLF3‑AS1 directly binds ETS Variant Transcription Factor 4 (ETV4) to activate Silent Information Regulator 3 (SIRT3), preserving mitochondrial integrity. BMSC‑derived exosomal KLF3‑AS1 promotes M2 microglial polarisation and ameliorates cerebral ischaemia–reperfusion injury.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reperfusion InjuryMicrogliaMesenchymal Stem CellsHistonesMitochondriaKruppel-Like Transcription FactorsBrain IschemiaAnimalsMiceAcetylationMaleDisease Models, AnimalExosomesMice, Inbred C57BL

Stichwörter der Autor:innen

KLF3‐AS1SIRT3bone marrow‐derived mesenchymal stem cellscerebral ischaemia‒reperfusion injurymicroglial polarisation

Substanzen

HistonesKruppel-Like Transcription Factors

Autor:innen und Institutionen

  • Department of Traditional Chinese Medicine, Hunan Provincial People's Hospital (The First Affiliated Hospital of Hunan Normal University), Changsha, China.
  • Clinical Nursing Teaching and Research Section, The Second Xiangya Hospital of Central South University, Changsha, China.
  • Department of Rehabilitation, Xiangya Boai Rehabilitation Hospital, Clinical Medical Technology Demonstration Base for Cerebrovascular Disease Rehabilitation in Hunan Province, Changsha, China.
  • Department of Comprehensive Surgery, Hunan Provincial People's Hospital (The First Affiliated Hospital of Hunan Normal University), Changsha, China.
  • Department of Neurosurgery, Hunan Provincial People's Hospital (The First Affiliated Hospital of Hunan Normal University), Changsha, China.

ORCID-Profile: Dingzhou Zhou

Förderung

  • Hunan Furong Program Young Talent Project
  • Health Research Project of Hunan Provincial Health Commission
  • Hunan Province Cerebrovascular Disease Rehabilitation Clinical Medical Technology Demonstration Base
  • Hunan Provincial Natural Science Foundation
  • Natural Science Foundation of Hunan Province

Zitieren

APA

Li, Q., Xie, X., Chen, J., Cao, Y., & Zhou, D. (2026). Intranuclear localisation of KLF3‐AS1 under the balance of histone acetylation and methylation in BMSCs ameliorates cerebral ischaemia‒reperfusion injury by preserving microglial mitochondrial function and inhibiting inflammatory polarisation. Clinical and Translational Medicine, 16(11). https://doi.org/10.1002/ctm2.70870

Vancouver

Li Q, Xie X, Chen J, Cao Y, Zhou D. Intranuclear localisation of KLF3‐AS1 under the balance of histone acetylation and methylation in BMSCs ameliorates cerebral ischaemia‒reperfusion injury by preserving microglial mitochondrial function and inhibiting inflammatory polarisation. Clinical and Translational Medicine. 2026;16(11). doi:10.1002/ctm2.70870

BibTeX
@article{Li2026,
  author = {Li, Qian and Xie, Xiaowei and Chen, Jie and Cao, Yu and Zhou, Dingzhou},
  title = {Intranuclear localisation of KLF3‐AS1 under the balance of histone acetylation and methylation in BMSCs ameliorates cerebral ischaemia‒reperfusion injury by preserving microglial mitochondrial function and inhibiting inflammatory polarisation},
  journal = {Clinical and Translational Medicine},
  year = {2026},
  volume = {16},
  number = {11},
  doi = {10.1002/ctm2.70870}
}
Kostenlos starten →